Mikel Ross on Patient Tolerability of Cooling Caps for Chemotherapy-Induced Hair Loss

Video

Mikel Ross discusses the cooling cap intervention for chemotherapy-induced hair loss and patients' tolerability.

Mikel Ross, BSN, RN, OCN, from Memorial Sloan Kettering Cancer Center, discusses the cooling cap intervention for chemotherapy-induced hair loss and how patients tolerated the treatment.

Patients seem to tolerate this intervention well. However, it does add time to the chemotherapy process, as a pre-cooling and post-cooling period is required. This time commitment is likely the main reason for discontinuation. Otherwise, there only seems to be a cold sensation that patients have reported.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Recent Videos
Photo of a woman with brown hair and bangs, surrounded by a blue border
Photo of an open bottle of pills
4 experts in this video
4 experts in this video
Photo of a woman wearing a blazer and a colorful scarf in front of a blue background
Related Content